NCT07382167Phase 3Recruiting

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Study sponsor: Ardelyx

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-02-26Estimated
Enrollment · participants692Estimated
Source updated2026-06-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Durable CSBM response. After: Measure: Durable complete spontaneous bowel movements (CSBM) response.

Check registry source